UPDATED 12/7/20 Download CVS Health Essential Personnel Access Letter:
CVS Health Essential Personnel Access Letter (ENGLISH)
CVS Health Essential Personnel Access Letter (SPANISH)
11/18/20 Download Travel Authorization Letter:
Travel Authorization Letter
11/4/20 Download CVS Health Essential Personnel Access Request Letter:
CVH Health Essential Personnel Access Request Letter
8/25/20 Download COVID-19 Essential Personnel Request for CVS:
COVID-19 Essential Personnel Request English 08242020
COVID-19 Essential Personnel Request Spanish 08242020
8/14/20 Download Flu Delivery Flyer for CVS:
Flu Delivery Flyer
7/10/20 Download Essential Supplier Access Documents for CVS:
COVID-19 Essential_Personnel_Access(ENGLISH)_10JUL20
COVID-19_Essential_Personnel_Access(SPANISH)_10JUL20
CIVIL-UNREST Essential Supplier Access Request 30 May 20
COVID-19 Essential Supplier Access Request ENGLISH 21 May 20
COVID-19 Essential Supplier Access Request SPANISH 21 May 20
Minor Update to COVID-19 Temperature
Screening Policy:
As of 6/2, the temperature screening
protocols that were implemented by PDI are being slightly modified to
align with customer protocols and procedures. Please note that
ONLY the temperature reading threshold for a fever has been
adjusted.
The same temperature procedures and
protocols will be in place, with the temperature threshold now at
100.0°F. As before, if a
reading of 99.9° or less is observed you will be granted access to
perform normal contractual duties. If your reading is of
100.0°F or higher and confirmed, you
will not be granted access to perform normal contractual duties and you
will not be allowed to return for 72 hours.
Upon your return after 72 hours with
the previous elevated temperature, you must have a temperature of 99.9°F
or lower to resume normal contractual duties.
Please reach out to your local
logistics team or dispatch with any further questions.
Thank you,
Jake Thomas
Director of Independent Contractor Relations
|

Delivery Changes
For Heartland effective 03/26/2020
All
deliveries will be made outside the facility at a predetermined area.
All totes now have separate bags inside. The totes will not be dropped
off at this time, only the bags inside the tote.
1.
The driver should call
the home 10 minutes prior to making their scheduled delivery.
2.
This will give the nurse
time to bring out any returns, empty totes, EDK boxes, etc…
3.
Driver will open all
totes and remove the contents. If the bag has control medications in it,
it will be locked with a black numbered lock as usual and a control
delivery sheet stapled to the outside of the bag.
4.
The driver will get a
P.O.D. for the bag and for the control bag that’s inside the bag. This
process will be followed for all bags/stations.
5.
All non-control bags
will be locked with purple locks as usual.
6.
We will place a tote
label on the bag so the nurse knows which station the bag goes to.
7.
Nurse will give driver
brown paper bag with return medications in them.
Returning medications:
We
will put brown paper bags in each tote to be used for returning
medications. These bags will have a green sticker “RETURN MEDS” on each
one before it arrives at your pharmacy. Please bring these out to your
driver at the designated meeting location. If you have any EDK exchanges
or pump returns, please bring those also.
ADM’S
Your ADM totes will follow the same procedure as your regular totes.
They will have a separate bag inside. This bag will be marked with a
yellow sticker “ADM RESTOCK MEDS FOR OMNICELL ONLY”. The control
manifest will also be stapled to the outside of the bag to be scanned by
driver to get a P.O.D.
Pumps
Instead of your red return totes, we will send you brown bags to return
your pumps. These bags will be marked with a red sticker “RETURN PUMP:
PLACE PUMP IN RED HAZARD BAG”. This brown bag will include a red
hazardous bag, bubble wrap, and delivery ticket.
|
MEMORANDUM
To:
All Independent Contractors & Vendors
From: Guy Cook, Compliance Manager
Date: March 2nd, 2020
Re: Interim
Guidance of the Coronavirus (COVID-19)
Purpose
This document provides interim guidance for independent contractors and vendors
to help prevent or detect suspected COVID-19 infections.
CDC will update this interim guidance as needed and as additional information
becomes available.
This interim guidance is based on what is currently known about the coronavirus
disease 2019 (COVID-19). The Centers for Disease Control and Prevention (CDC)
will update this interim guidance as needed and as additional information
becomes available.
CDC is working across the Department of Health and Human Services and across the
U.S. government in the public health response to COVID-19. Much is unknown about
how the virus that causes COVID-19 spreads. Current knowledge is largely based
on what is known about similar coronaviruses.
The following interim guidance may help prevent exposures to acute respiratory
illnesses, including COVID-19, in non-healthcare settings.
Early detection, prevention, and control of Coronavirus Disease 2019 (COVID-19)
is important to protect the health of associates, couriers, vendors and our
customers.
Reducing the Spread
To reduce the spread of respiratory infections including COVID-19, the CDC
recommends:
• Postpone travel when sick
• Watch your health
• Self-isolate and inform medical center immediately if you develop a fever
(100.4oF / 38oC or higher), begin to feel feverish, or develop other signs or
symptoms of sickness
• Use respiratory, cough, and hand hygiene
o Importance of covering coughs and sneezes with a
tissue. Dispose used tissues immediately in a disposable container (e.g.,
plastic bag) or a washable trash can.
o Wash hands often with soap and water, especially
after coughing or sneezing. (If soap and water is not available, then you can
use a hand sanitizer containing 60%-95% alcohol).
Symptoms
Symptoms may include fever, cough, and shortness of breath. Patients have a
fever if they feel warm to the touch, give a history of feeling feverish, or
have a measured temperature of 100.4°F (38°C) or higher. COVID-19 infections
have ranged from little-to-no symptoms to severe illness and death. The
incubation period is believed to be 2–14 days.
We will provide additional information, as provided from the CDC.
|